Integra Clinical Research LLC is categorized under Medical Labs in San Antonio, TX and active since 2004.
Integra Clinical Research LLC was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Suzanne K Gazda at the company’s single location by writing to 3603 Paesanos Parkway # 120, San Antonio, Texas TX 78231 or by phoning (210) 614-4884. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Integra Clinical Research LLC |
| Contact Person: | Suzanne K Gazda |
| Address: | 3603 Paesanos Parkway # 120, San Antonio, Texas 78231 |
| Phone Number: | (210) 614-4884 |
| Website Address: | callintegra.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Integra Clinical Research LLC was started in 2004 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Suzanne K Gazda for inquiries that concern Integra Clinical Research LLC by calling the company number (210) 614-4884, as your correspondence is most welcome. Additionally, the physical location of the single location of Integra Clinical Research LLC can be found at the coordinates 29.599983,-98.551786 as well as the street address 3603 Paesanos Parkway # 120 in San Antonio, Texas 78231.
For its online presence, you may visit Integra Clinical Research LLC’s website at callintegra.com and engage with its social media outlets through on Twitter and on Facebook.